Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Novel, nonviral gene delivery method in development at Genteric; U.S. patent issued

Jan. 20, 2000

SBIR grant awarded to Vion to advance preclinical development of TAPET vectors

Jan. 20, 2000

Gliatech and Abgenix enter XenoMouse technology collaboration

Jan. 20, 2000

Oxford BioMedica's LentiVector has potential application in cancer

Jan. 20, 2000

Phoenix and CuraGen enter transgenic research agreement

Jan. 20, 2000

AxyS announces combinatorial chemistry agreement with Searle

Jan. 19, 2000

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Jan. 19, 2000

Xechem awarded SBIR grant for marine extremophile research

Jan. 19, 2000

Patent coverage granted for Cell Genesys's third-generation lentiviral vectors

Jan. 18, 2000

Protein Design Labs and Celltech Chiroscience enter antibody patent agreement

Jan. 18, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...